Antibiotic Levels in Neonates on Continuous Kidney Support Therapy
Saturday, April 23, 2022
4:00 PM – 4:15 PM US MT
Location: Convention Center: Mile High Ballroom 3AB
CE: Enduring CME: 0.25
Publication Number: 1635.3
Emily P. Evans, Children's of Alabama, birmingham, AL, United States; Mary Silverberg, University of Alabama at Birmingham, Birmingham, AL, United States; David Askenazi, University of Alabama at Birmingham, Birmingham, AL, United States; Kara Short, Children's of Alabama, IRONDALE, AL, United States
Presenting Author(s)
Emily P. Evans, PharmD
Neonatal Critical Care Pharmacist Children's of Alabama birmingham, Alabama, United States
Participants should be aware of the following financial/non-financial relationships:
Emily P. Evans, PharmD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Mary Silverberg, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
David Askenazi, MD, MSPH: ● Baxter (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant). ● Bioporto (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant). ● Medtronic (Products/Services: Consultant). ● Nuwellis (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant). ● Seastar (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant).
Kara Short, Short, Master of Science in Nursing: I do not have any relevant financial / non-financial relationships with any proprietary interests.
.jpg "Emily P. Evans, PharmD photo")